1. Adelson P, Peacock W, Chugani H i wsp. Temporal and ex tended temporal resections for the treatment of intracta ble seizures in early childhood. Pediatr Neurosurg 1992; 18: 169-178.
2.
Alexopoulos AV, Kotagal P, Loddenkemper T, Hammel J, Bin gaman WE. Long-term results with vagus nerve stimulation in children with pharmacoresistant epilepsy. Seizure 2006; 15: 491-503.
3.
Arora N, Mehta TR. Role of the ketogenic diet in acute neu rological diseases. Clinical Neurology and Neurosurgery 2020; 192.
4.
Azevedo de Lima P, Pereira de Brito Sampaio L, Texiera Dama sceno NR. Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy. Clinics (Sao Paulo) 2014; 69(10): 699-705.
5.
Barzegar M, Afghan M, Tarmahi V, Behtari M, Rihimi Kha maneh S, Raeisi S. Ketogenic diet: overview, types, and pos sible anti-seizure mechanisms. Nutr Neurosci 2019; 1-10.
6.
Bellebaum C, Daum I. Learning-related changes in reward expectancy are reflected in the feedback-related negativity. Eur J Neurosci 2008; 27: 1823-1835.
7.
Ben-Menachem E. Neurostimulation – past, present, and beyond. Epilepsy Curr 2012; 12: 188–191.
8.
Berg AT. Identification of Pharmacoresistant Epilepsy. Neu rol Clin. 2009; 27(4).
9.
Boon P, Vonck K, De Herdt V, Van Dycke A, Goethals M, Goos sens L i wsp. Deep brain stimulation in patients with refrac tory temporal lobe epilepsy. Epilepsia 2007; 48(8): 1551-1560.
10.
Cersosimo RO, Bartuluchi M, Fortini S, Soraru A, Pomata H, Caraballo RH. Vagus nerve stimulation: effectiveness and tol erability in 64 paediatric patients with refractory epilepsies Epileptic Disord 2011; 13: 382-388.
11.
Cervenka MC, Hocker S, Koenig M, Bar B, Henry-Barron B, Kossoff EH et al. Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticus. Neurology 2017; 88(10): 938-943.
12.
Chen Z, Brodie MJ, Liew D, Kwan P. Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Lon gitudinal Cohort Study. JAMA Neurol 2018; 75(3): 279-286.
13.
Chomtho K, Suteerojntrakool O, Chomtho S. Effectiveness of Medium Chain Triglyceride Ketogenic Diet in Thai Chil dren with Intractable Epilepsy. J Med Assoc Thai 2016; 99(2): 159-165.
14.
Chorągiewicz T, Żarnowska T, Gasior M, Żarnowski T. An ticonvulsant and neuroprotective effects of the ketogenic diet. Przegl Lek 2010; 67(3): 205-212.
15.
Connor DE, Nixon M, Nanda A, Guthikonda B. Vagal nerve stimulation for the treatment of medically refractory epi lepsy: a review of the current literature. Neurosurg Focus 2012; 32(3).
16.
Coppola G, Veggiotti P, Cusmai R, Bertoli S, Cardinali S, Di onisi-Vici C et al. The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an Italian multi centric experience. Epilepsy Res 2002; 48(3): 221-227.
17.
Cossu M, Lo Russo G, Fancione S, Mai R, Nobili L, Sartori I et al. Epilepsy surgery in children: results and predictors of outcome on seizures. Epilepsia 2008; 49: 65-72.
18.
Dahlin M, Martin DA, Hedlund Z, Jonsson M, von Döbeln U, Wedell A. The ketogenic diet compensates for AGC1 deficien cy and improves myelination. Epilepsia 2015; 56(11): 176-181.
19.
D’Andrea Meira I, Romao TT, Pirez do Prado HJ, Kruger LT, Paiva Pires ME, Oliviera da Conceicao P. Ketogenic diet and Epilepsy: What We Know So Far. Front Neurosci 2019; 13(5).
20.
deCampo DM, Kossoff EH. Ketogenic dietary therapies for epilepsy and beyond. Curr Opin Clin Nutr Metab Care 2019; 22(4): 264-268.
21.
Elliott RE, Rodgers SD, Bassani L, Morsi A, Geller EB, Carl son C et al. Vagus nerve stimulation for children withtreatment-resistant epilepsy: a consecutive series of 141 cases. J Neurosurg Pediatr 2011; 7: 491-500.
22.
Engel J. Epilepsy surgery. Curr. Opin. Neurol. 1994; 7: 140–147.
23.
Englot DJ, Hassnain KH, Rolston JD, Harward SC, Sinha SR, Haglund MM. Quality-of-life metrics with vagus nerve stim ulation for epilepsy from provider survey data. Epilepsy Behav 2017; 66: 4-9.
24.
Fiest KM, Sajobi TT. Wiebe S. Epilepsy surgery and mean ingful improvements in quality of life: results from a ran domized controlled trial. Epilepsia 2014; 55(6): 886-892.
25.
Fisher R, Salanova V, Witt T et al. SANTE Study Group: Elec trical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 2010; 51: 899-908.
26.
Fisher RS, Velasco AL. Electrical brain stimulation for epi lepsy. Nature Reviews Neurology 2014; 10: 261-270.
27.
Francis BA, Fillenworth J, Gorelick P, Karanec K, Tanner A. The feasibility, safety and effectiveness of a ketogenic diet for refractory status epilepticus in adults in the intensive care unit. Neurocrit Care 2019; 30: 652-657.
28.
Gardner J. A history of deep brain stimulation: Technological innova-tion and the role of clinical assessment tools. Soc Stud Sci 2013; 43: 707-728.
29.
Gulati S. Dietary Therapies: Emerging Paradigms in Therapy of Drug Resistant Epilepsy in Children : Based on 6th Dr. I. C. Verma Excellence in Research Award Oration. Indian J Pediatr 2018; 85(11): 1000-1005.
30.
Guldvog B, Loyning Y, Hauglie-Hanssen E, Flood S, Bjornaes H. Surgical treatment for partial epileps among Norwegian children and adolescents. Epilepsia 1994; 35: 554-565.
31.
Hallbook T, Tideman P, Rosen I, Lundgren J, Tideman E. Epilepsy surgery in children with drug-resistant epilep sy, a long-term follow-up. Acta Neurol Scand 2013; 128: 414-421.
32.
Handforth A, DeGiorgio CM, Schachter SC, Uthman BM, Na ritoku DK, Tecoma ES et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998; 51: 48-55.
33.
Hartman AL, Gasior M, Vining EP, Rogawski MA. Theneu ropharmacology of the ketogenic diet. Pediatr Neurol 2007; 36(5): 281-292.
34.
Harvey KL, Holcomb LE, Kolwicz SC. Ketogenic Diets and Exercise Performance. Nutrients 2019; 11(10).
35.
Helmers SL, Wheless JW, Frost M, Gates J, Levisohn P, Tardo C et al. Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: retrospective study J Child Neurol 2001; 16: 843-848.
36.
Husari KS, Cervenka MC. The ketogenic diet all grown up-Ketogenic diet terapies for adults. Epilepsy Res. 2020.
37.
Huttenlocher PR, Wilbourn AJ, Signore JM. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology 1971; 21(11): 1097-1103.
38.
Jędrzejczak J, Majkowska-Zwolińska B, Ryglewicz D et al.Zalecenia Polskiego Towarzystwa Epileptologii dotyczące leczenia napadów padaczkowych u dorosłych. Aktualizacja. J Epileptol 2019; 27(1): 5-12 .
39.
Kaczorowska B, Pawełczyk M, Przybyła M. Chirurgiczne me tody leczenia padaczki. Aktualn Neurol 2012; 12(3): 159-163.
40.
Kang HC, Chung DE, Kim DW, Kim HD. Early - and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004; 4: 1116–1123.
41.
Keene D, Higgins M, Ventureyra E. Outcome and life pros pects after surgical management of medically intractable epilepsy in patients under 18 years of age. Childs Nerv Syst 1997; 13: 530-535.
42.
Khabbush A, Orford M, Tsai YC, Rutherford T, O’Donnell M, Eaton S et al. Neuronal decanoic acid oxidation is markedly lower than that of octanoic acid: A mechanistic insight into the medium-chain triglyceride ketogenic diet. Epilepsia 2017; 58(8): 1423-1429.
43.
Kim JA, Yoon JR, Lee EJ, Lee JS, Kim JT, Kim HD et al. Effica cy of the classic ketogenic and the modified Atkinsdiets in refractory childhood epilepsy. Epilepsia 2016; 57(1): 51-8.
44.
Klinger NV, Mittal S. Clinical efficacy of deep brain stimula tion for the treatment of medically refractory epilepsy. Clin Neurol Neurosurg 2016; 140: 11-25.
45.
Kossoff EH, Shields WD. Nonpharmacologic care forpatients with lennox-gastaut syndrome: ketogenicdiets and vagus nerve stimulation. Epilepsia 2014; 55(4): 29-33.
46.
Krishna V, Sammartino F, King NKK, So RQY, Wennberg R. Neuromodulation for epilepsy. Neurosurg Clin N Am 2016; 27: 123-131.
47.
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Hauster WA, Ma theron G et al. Definition of Drug Resistant Epilepsy: Consensus Proposal by the Ad Hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51(6): 1069-1070.
48.
Laxpati NG, Kasoff WS, Gross RE. Deep brain stimulation for the treatment of epilepsy: circuits, targets, and trials. Neurotherapeu-tics 2014; 11: 508-526.
49.
Lefevre F, Aronson N. Ketogenic diet for the treatment ofre fractory epilepsy in children: a systematic review ofefficacy. Pediatrics 2000; 105(4): 46.
50.
Li Z, Heber D. Ketogenic Diets. JAMA 2020; 323(4): 386.
51.
Liu YM, Wang HS. Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a com parison with other ketogenic diets. Biomed J 2013; 36(1): 9-15.
52.
Mahmoud SH, Ho-Huang E, Buhler J. Systematic review of ketogenic diet use in adult patients with status epilepticus. Epilepsia Open 2019; 5(1): 10-21.
53.
Menachem EB, Manon-Espaillat R, Ristanovic R, Wilder BJ, Stefan H, Mirza W et al. Vagus nerve stimulation for treat ment of partial seizures: 1. A controlled study of effect on seizures. First International Vagus Nerve Stimulation Study Group. Epilepsia 1994; 35(3): 616-626.
54.
Morrison G, Duchowny M, Resnick T, Alvarez L, Jayakar P, Prats AR et al. Epilepsy surgery in childhood. Pediatr Neu rosurg 1992; 18: 291-297.
55.
Neal EG, Chaffe H, Schwartz RH, Lawson MS, EdwardsN, Fitzsimmons G et al. A randomized trial of classicaland me dium-chain triglyceride ketogenic diets in thetreatment of childhood epilepsy. Epilepsia 2009; 50(5): 1109-17.
56.
Oldham MS, Horn PS, Tsevat J, Standridge S. Costs and Clinical Outcomes of Epilepsy Surgery in Children With Drug-Resistant Epilepsy. Pediatr Neurol 2015; 53(3): 216-220.
57.
Park EG, Lee J. The ketogenic diet for super‐refractory status epilepticus patients in intensive care units. Brain Dev 2019; 41: 420-427.
58.
Payne NE, Cross JH, Sander JW, Sisodiya SM. The ketogenic and related dietes in adolescents and adults – A review. Epi lepsia 2011; 52(11): 1941-1958.
59.
Poff AM, Rho JM, A’Agostino DP. Ketone Administration for Seizure Disorders: History and Rationale for Ketone Esters and Metabolic Alternatives. Front Neurosci 2019; 13: 1041.
60.
Potasz-Kulikowska K. Wpływ głębokiej stymulacji mózgu na funkcje poznawcze i emocjonalne u chorych na epilepsję – przegląd badań. Aktualn Neurol 2017; 17(2): 87-95.
61.
Prasad AN, Stafstrom CE. Dietary therapy of epilepsy in the nineties; renewed experience with the ketogenic diet. Nutrition Research 1998; 18(2): 403-416.
62.
Prasoppokakorn T, Jirasakuldej S, Lakananurak N. Medi um-chain triglyceride ketogenic diet is effective for treat ment of an adult with super-refractory status epilepticus: a case report and literature review. Eur J Clin Nutr 2019; 73(12): 1594-1597.
63.
Rejdak K, Rola R, Mazurkiewicz-Bełdzińska M, Halczuk I, Błaszczyk B, Rysz A et al. Diagnostyka i leczenie padaczki u osób dorosłych – rekomendacje Polskiego Towarzystwa Neu rologicznego. Polski Przegląd Neurologiczny 2016; 12(1): 15-27.
64.
Rho JM. How does the ketogenic diet induce anti-seizure effects? Neurosci Lett 2017; 637: 4-10.
65.
Ryvlin P, Cross JH, Rheims S. Epilepsy surgery in children and adults. The Lancet Neurology 2014; 13(11): 1114-1126 (a).
66.
Ryvlin P, Gilliam FG, Nguyen DK, Colicchio G, Iudice A, Tin uper P et al. The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (open prospective randomized long-term effectiveness) trial Epilepsia 2014; 55: 893-900 (b).
67.
Sampaio LP. Ketogenic diet for epilepsy treatment. Arg Neu ropsiquiatr 2016; 74(10): 842-848.
68.
Schaller K, Cabrilo I. Corpus callosotomy. Acta Neurochirur gica 2015; 158: 155-160.
69.
Schoeler NE, Cross JH. Ketogenic dietary therapies in adults with epilepsy: a practical guide. Practical Neurology 2016; 16(3): 208-214.
70.
Schoeler NE, Wood S, Aldridge V, Sander JW, Cross JH, Sisodi ya SM. Ketogenic dietary therapies for adults with epilepsy: feasibility and classification of response. Epilepsy Behav 2014; 37: 77-81.
71.
Sheng J, Liu S, Qin H, Li B, Zhang X. Drug-Resistant Epilepsy and Surgery 2018; 16(1): 17-28.
72.
Spencer S, Huh L. Outcomes of epilepsy surgery in adults and children. Lancet Neurol 2008; 7: 525-537.
73.
Szczerbicki M, Maksymowicz W, Bacia T, Barczewska M. Chirurgiczne leczenie padaczki. Problemy Lekarskie 2006; 45(1): 27-30.
74.
Thakur KT, Probasco JC, Hocker SE, Roehl K, Henry B, Kos soff EH et al. Ketogenic diet for adults in super-refractory status epilepticus. Neurology 2014; 82(8): 665-670.
75.
Warren EC, Walker MC, Williams RSB. All You Need Is Fats for Seizure Control: Using Amoeba to Advance Epilepsy Re search. Front Cell Neurosci 2018; 12: 199.
76.
West S, Nolan SJ, Newton R. Surgery for epilepsy:a systematic review of current evidence. Epileptic Disord. 2016; 18(2): 113-121.
77.
Wheless JW, Gienapp AJ, Ryvlin P. Vagus nerve stimulation (VNS) therapy update. Epilepsy Behav. 2018; 88: 2-10.
78.
Wiebe S., Blume W.T., Girvin J.P., Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N. Engl. J. Med. 2001; 345(5): 311-318.
79.
Wilder RM. High fat diets in epilepsy. Mayo Clin. Bull. 1921; 2: 308.
80.
Winesett SP, Kordecki Bessone S, Kossof EHW. The ketogenic diet in pharmacoresistant childhood epilepsy. Expert review of neurotherapeutics 2015; 15(6): 621-628.
81.
Wyllie E, Comair YG, Kotagal P, Bulacio J, Bing-Aman W, Rug gieri P. Seizure outcome after epilepsy surgery in children and adolescents. Ann Neurol 1998; 44: 740-748.
82.
Xue-Ping W, Hai-Jiao W, Li-Na Z, Xu D, Ling L. Risk Fac tors for Drug-Resistant Epilepsy: A Systematic Review and Meta-Analysis. Medicine (Baltimore) 2019; 98(30): 16402.
83.
Youngosn NA, Morris MJ, Ballard WO. The mechanisms mediating the antiepileptic effects of the ketogenic diet, and potential opportunities for improvement with metab olism-altering drugs. Seizure 2017; 52: 15-19.
